Jupiter Life Line Hospitals Balance Sheet
- Market cap
- ₹8,325 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹182.84 – ₹342.83
As of FY25, Jupiter Life Line Hospitals had total assets of ₹5,411 crore and borrowings of ₹999 crore, against shareholders' equity of ₹3,866 crore — a debt-to-equity ratio of 0.35.
Jupiter Life Line Hospitals balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 3,746 |
| Borrowings | 999 |
| Other liabilities | 666 |
| Total liabilities | 5,411 |
| Fixed assets | 2,914 |
| Capital work in progress | 45 |
| Investments | 1,249 |
| Other assets | 1,249 |
| Total assets | 5,411 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹89.11
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Jupiter Life Line Hospitals balance sheet — frequently asked questions
What is the total debt of Jupiter Life Line Hospitals?
Jupiter Life Line Hospitals reported borrowings of ₹999 crore as of FY25.
What is Jupiter Life Line Hospitals' debt-to-equity ratio?
Based on the FY25 balance sheet, Jupiter Life Line Hospitals' debt-to-equity ratio is 0.35 — borrowings of ₹999 crore against equity capital and reserves of ₹3,866 crore.
What are Jupiter Life Line Hospitals' total assets?
Jupiter Life Line Hospitals' total assets were ₹5,411 crore as of FY25, including fixed assets of ₹2,914 crore and investments of ₹1,249 crore.
What is the book value per share of Jupiter Life Line Hospitals?
The book value per share of Jupiter Life Line Hospitals is ₹89.11, based on the latest reported balance sheet.
Same Data For Peers
Trade Jupiter Life Line Hospitals With ATS
Track JLHL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.